Health
updatedToad-Venom Compound Nasal Spray Eased Depression in Phase 2b Trial
In a phase 2b JAMA trial of 193 adults, a single nasal dose of mebufotenin eased treatment-resistant depression for at least eight weeks; an outside psychiatrist urges caution.
JAMA•3 min read
